Morningside Venture Investments Ltd

Morningside Venture Investments Ltd is a declared insider at 5 companies; the most frequent names are Kezar Life Sciences, Inc., Amylyx Pharmaceuticals, Inc. and Apnimed, Inc. Between 13 January 2020 and 3 August 2026, the trades on record add up to 36 filings.

The open-market side counts 5 purchases for €51.7M alongside 18 sales for €11.8M. Netting one side against the other leaves €39.9M of net buying. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2026 alone, the filings show 1 purchase and no sales.

In size, the median ticket on the buying side is €8.9M. Clusters matter here: 2 out of 3 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

Most recently, on 5 August 2026, the filings show a transaction in Apnimed, Inc. The clock since the last published purchase (5 August 2026) now reads 80 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.